nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—ESR1—Alzheimer's disease	0.477	1	CbGaD
Levonorgestrel—CYP3A4—Rivastigmine—Alzheimer's disease	0.0583	0.432	CbGbCtD
Levonorgestrel—CYP3A4—Donepezil—Alzheimer's disease	0.0466	0.345	CbGbCtD
Levonorgestrel—CYP3A4—Galantamine—Alzheimer's disease	0.03	0.223	CbGbCtD
Levonorgestrel—SRD5A1—forebrain—Alzheimer's disease	0.00513	0.114	CbGeAlD
Levonorgestrel—SRD5A1—telencephalon—Alzheimer's disease	0.00472	0.105	CbGeAlD
Levonorgestrel—PGR—blood vessel—Alzheimer's disease	0.00319	0.071	CbGeAlD
Levonorgestrel—SRD5A1—nervous system—Alzheimer's disease	0.00279	0.062	CbGeAlD
Levonorgestrel—SRD5A1—central nervous system—Alzheimer's disease	0.00268	0.0597	CbGeAlD
Levonorgestrel—ESR1—blood vessel—Alzheimer's disease	0.0025	0.0555	CbGeAlD
Levonorgestrel—SRD5A1—brain—Alzheimer's disease	0.00213	0.0474	CbGeAlD
Levonorgestrel—CYP19A1—forebrain—Alzheimer's disease	0.00152	0.0337	CbGeAlD
Levonorgestrel—ESR1—embryo—Alzheimer's disease	0.00149	0.0331	CbGeAlD
Levonorgestrel—AR—forebrain—Alzheimer's disease	0.00134	0.0298	CbGeAlD
Levonorgestrel—ESR1—forebrain—Alzheimer's disease	0.00132	0.0293	CbGeAlD
Levonorgestrel—AR—telencephalon—Alzheimer's disease	0.00123	0.0274	CbGeAlD
Levonorgestrel—ESR1—telencephalon—Alzheimer's disease	0.00121	0.0269	CbGeAlD
Levonorgestrel—SHBG—central nervous system—Alzheimer's disease	0.000977	0.0217	CbGeAlD
Levonorgestrel—SHBG—cerebellum—Alzheimer's disease	0.000955	0.0212	CbGeAlD
Levonorgestrel—PGR—nervous system—Alzheimer's disease	0.000914	0.0203	CbGeAlD
Levonorgestrel—PGR—central nervous system—Alzheimer's disease	0.00088	0.0196	CbGeAlD
Levonorgestrel—PGR—cerebellum—Alzheimer's disease	0.00086	0.0191	CbGeAlD
Levonorgestrel—Nandrolone decanoate—MAOB—Alzheimer's disease	0.000827	0.139	CrCbGaD
Levonorgestrel—CYP19A1—nervous system—Alzheimer's disease	0.000823	0.0183	CbGeAlD
Levonorgestrel—CYP19A1—central nervous system—Alzheimer's disease	0.000792	0.0176	CbGeAlD
Levonorgestrel—SHBG—brain—Alzheimer's disease	0.000776	0.0173	CbGeAlD
Levonorgestrel—AR—nervous system—Alzheimer's disease	0.000728	0.0162	CbGeAlD
Levonorgestrel—ESR1—nervous system—Alzheimer's disease	0.000715	0.0159	CbGeAlD
Levonorgestrel—AR—central nervous system—Alzheimer's disease	0.000701	0.0156	CbGeAlD
Levonorgestrel—PGR—brain—Alzheimer's disease	0.000699	0.0155	CbGeAlD
Levonorgestrel—Danazol—CCL2—Alzheimer's disease	0.000696	0.117	CrCbGaD
Levonorgestrel—ESR1—central nervous system—Alzheimer's disease	0.000688	0.0153	CbGeAlD
Levonorgestrel—Quinestrol—ESR1—Alzheimer's disease	0.000685	0.115	CrCbGaD
Levonorgestrel—ESR1—cerebellum—Alzheimer's disease	0.000673	0.015	CbGeAlD
Levonorgestrel—CYP19A1—brain—Alzheimer's disease	0.000629	0.014	CbGeAlD
Levonorgestrel—Ethynodiol—ESR1—Alzheimer's disease	0.000564	0.0945	CrCbGaD
Levonorgestrel—AR—brain—Alzheimer's disease	0.000557	0.0124	CbGeAlD
Levonorgestrel—ESR1—brain—Alzheimer's disease	0.000547	0.0122	CbGeAlD
Levonorgestrel—Allylestrenol—ESR1—Alzheimer's disease	0.000533	0.0893	CrCbGaD
Levonorgestrel—Mestranol—ESR1—Alzheimer's disease	0.000519	0.087	CrCbGaD
Levonorgestrel—Desogestrel—ESR1—Alzheimer's disease	0.000513	0.0859	CrCbGaD
Levonorgestrel—Norgestimate—ESR1—Alzheimer's disease	0.00048	0.0804	CrCbGaD
Levonorgestrel—Sweating increased—Rivastigmine—Alzheimer's disease	0.000458	0.00183	CcSEcCtD
Levonorgestrel—Muscle spasms—Galantamine—Alzheimer's disease	0.000458	0.00183	CcSEcCtD
Levonorgestrel—Bronchitis—Rivastigmine—Alzheimer's disease	0.000452	0.00181	CcSEcCtD
Levonorgestrel—Dysuria—Memantine—Alzheimer's disease	0.00045	0.0018	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000447	0.00179	CcSEcCtD
Levonorgestrel—Pollakiuria—Memantine—Alzheimer's disease	0.000444	0.00177	CcSEcCtD
Levonorgestrel—Anaemia—Galantamine—Alzheimer's disease	0.00044	0.00176	CcSEcCtD
Levonorgestrel—Dysuria—Rivastigmine—Alzheimer's disease	0.00044	0.00176	CcSEcCtD
Levonorgestrel—Weight increased—Memantine—Alzheimer's disease	0.000438	0.00175	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000437	0.00175	CcSEcCtD
Levonorgestrel—Weight decreased—Memantine—Alzheimer's disease	0.000435	0.00174	CcSEcCtD
Levonorgestrel—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000435	0.00174	CcSEcCtD
Levonorgestrel—Pneumonia—Memantine—Alzheimer's disease	0.000431	0.00172	CcSEcCtD
Levonorgestrel—Infestation—Memantine—Alzheimer's disease	0.000429	0.00171	CcSEcCtD
Levonorgestrel—Infestation NOS—Memantine—Alzheimer's disease	0.000429	0.00171	CcSEcCtD
Levonorgestrel—Weight increased—Rivastigmine—Alzheimer's disease	0.000428	0.00171	CcSEcCtD
Levonorgestrel—Vertigo—Galantamine—Alzheimer's disease	0.000428	0.00171	CcSEcCtD
Levonorgestrel—Depression—Memantine—Alzheimer's disease	0.000428	0.00171	CcSEcCtD
Levonorgestrel—Syncope—Galantamine—Alzheimer's disease	0.000427	0.00171	CcSEcCtD
Levonorgestrel—Haemoglobin—Donepezil—Alzheimer's disease	0.000426	0.0017	CcSEcCtD
Levonorgestrel—Weight decreased—Rivastigmine—Alzheimer's disease	0.000426	0.0017	CcSEcCtD
Levonorgestrel—Rhinitis—Donepezil—Alzheimer's disease	0.000425	0.0017	CcSEcCtD
Levonorgestrel—Haemorrhage—Donepezil—Alzheimer's disease	0.000424	0.00169	CcSEcCtD
Levonorgestrel—Pneumonia—Rivastigmine—Alzheimer's disease	0.000422	0.00169	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000422	0.00169	CcSEcCtD
Levonorgestrel—Palpitations—Galantamine—Alzheimer's disease	0.000421	0.00168	CcSEcCtD
Levonorgestrel—Pharyngitis—Donepezil—Alzheimer's disease	0.000421	0.00168	CcSEcCtD
Levonorgestrel—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000419	0.00168	CcSEcCtD
Levonorgestrel—Infestation—Rivastigmine—Alzheimer's disease	0.000419	0.00168	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000419	0.00167	CcSEcCtD
Levonorgestrel—Loss of consciousness—Galantamine—Alzheimer's disease	0.000419	0.00167	CcSEcCtD
Levonorgestrel—Depression—Rivastigmine—Alzheimer's disease	0.000418	0.00167	CcSEcCtD
Levonorgestrel—Urinary tract infection—Memantine—Alzheimer's disease	0.000417	0.00167	CcSEcCtD
Levonorgestrel—Urethral disorder—Donepezil—Alzheimer's disease	0.000416	0.00166	CcSEcCtD
Levonorgestrel—Cough—Galantamine—Alzheimer's disease	0.000416	0.00166	CcSEcCtD
Levonorgestrel—Etonogestrel—ESR1—Alzheimer's disease	0.000415	0.0696	CrCbGaD
Levonorgestrel—Hypertension—Galantamine—Alzheimer's disease	0.000411	0.00164	CcSEcCtD
Levonorgestrel—Visual impairment—Donepezil—Alzheimer's disease	0.000409	0.00163	CcSEcCtD
Levonorgestrel—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000408	0.00163	CcSEcCtD
Levonorgestrel—Myalgia—Galantamine—Alzheimer's disease	0.000405	0.00162	CcSEcCtD
Levonorgestrel—Chest pain—Galantamine—Alzheimer's disease	0.000405	0.00162	CcSEcCtD
Levonorgestrel—Anxiety—Galantamine—Alzheimer's disease	0.000404	0.00161	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000403	0.00161	CcSEcCtD
Levonorgestrel—Sinusitis—Memantine—Alzheimer's disease	0.000402	0.00161	CcSEcCtD
Levonorgestrel—Discomfort—Galantamine—Alzheimer's disease	0.000401	0.0016	CcSEcCtD
Levonorgestrel—CYP3A4—nervous system—Alzheimer's disease	0.000399	0.00888	CbGeAlD
Levonorgestrel—Sinusitis—Rivastigmine—Alzheimer's disease	0.000394	0.00157	CcSEcCtD
Levonorgestrel—Haemoglobin—Memantine—Alzheimer's disease	0.000387	0.00155	CcSEcCtD
Levonorgestrel—Rhinitis—Memantine—Alzheimer's disease	0.000386	0.00154	CcSEcCtD
Levonorgestrel—Haemorrhage—Memantine—Alzheimer's disease	0.000385	0.00154	CcSEcCtD
Levonorgestrel—CYP3A4—central nervous system—Alzheimer's disease	0.000384	0.00855	CbGeAlD
Levonorgestrel—Hypoaesthesia—Memantine—Alzheimer's disease	0.000383	0.00153	CcSEcCtD
Levonorgestrel—Shock—Galantamine—Alzheimer's disease	0.000382	0.00153	CcSEcCtD
Levonorgestrel—Pharyngitis—Memantine—Alzheimer's disease	0.000382	0.00153	CcSEcCtD
Levonorgestrel—Nervous system disorder—Galantamine—Alzheimer's disease	0.000381	0.00152	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Memantine—Alzheimer's disease	0.00038	0.00152	CcSEcCtD
Levonorgestrel—Arrhythmia—Donepezil—Alzheimer's disease	0.000379	0.00151	CcSEcCtD
Levonorgestrel—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000378	0.00151	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Memantine—Alzheimer's disease	0.000378	0.00151	CcSEcCtD
Levonorgestrel—Rhinitis—Rivastigmine—Alzheimer's disease	0.000378	0.00151	CcSEcCtD
Levonorgestrel—Skin disorder—Galantamine—Alzheimer's disease	0.000378	0.00151	CcSEcCtD
Levonorgestrel—Urethral disorder—Memantine—Alzheimer's disease	0.000377	0.00151	CcSEcCtD
Levonorgestrel—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000377	0.0015	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000376	0.0015	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000375	0.0015	CcSEcCtD
Levonorgestrel—Alopecia—Donepezil—Alzheimer's disease	0.000375	0.0015	CcSEcCtD
Levonorgestrel—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000374	0.00149	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000372	0.00149	CcSEcCtD
Levonorgestrel—Mental disorder—Donepezil—Alzheimer's disease	0.000371	0.00148	CcSEcCtD
Levonorgestrel—Visual impairment—Memantine—Alzheimer's disease	0.000371	0.00148	CcSEcCtD
Levonorgestrel—Anorexia—Galantamine—Alzheimer's disease	0.00037	0.00148	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00037	0.00148	CcSEcCtD
Levonorgestrel—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000369	0.00147	CcSEcCtD
Levonorgestrel—Malnutrition—Donepezil—Alzheimer's disease	0.000369	0.00147	CcSEcCtD
Levonorgestrel—Erythema—Donepezil—Alzheimer's disease	0.000369	0.00147	CcSEcCtD
Levonorgestrel—Erythema multiforme—Memantine—Alzheimer's disease	0.000364	0.00145	CcSEcCtD
Levonorgestrel—Flatulence—Donepezil—Alzheimer's disease	0.000364	0.00145	CcSEcCtD
Levonorgestrel—Visual impairment—Rivastigmine—Alzheimer's disease	0.000363	0.00145	CcSEcCtD
Levonorgestrel—Tension—Donepezil—Alzheimer's disease	0.000362	0.00145	CcSEcCtD
Levonorgestrel—Eye disorder—Memantine—Alzheimer's disease	0.00036	0.00144	CcSEcCtD
Levonorgestrel—Nervousness—Donepezil—Alzheimer's disease	0.000358	0.00143	CcSEcCtD
Levonorgestrel—Cardiac disorder—Memantine—Alzheimer's disease	0.000357	0.00143	CcSEcCtD
Levonorgestrel—Back pain—Donepezil—Alzheimer's disease	0.000357	0.00143	CcSEcCtD
Levonorgestrel—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000356	0.00142	CcSEcCtD
Levonorgestrel—Muscle spasms—Donepezil—Alzheimer's disease	0.000355	0.00142	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000354	0.00141	CcSEcCtD
Levonorgestrel—Eye disorder—Rivastigmine—Alzheimer's disease	0.000352	0.00141	CcSEcCtD
Levonorgestrel—Insomnia—Galantamine—Alzheimer's disease	0.000352	0.0014	CcSEcCtD
Levonorgestrel—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000349	0.0014	CcSEcCtD
Levonorgestrel—Immune system disorder—Memantine—Alzheimer's disease	0.000348	0.00139	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Memantine—Alzheimer's disease	0.000347	0.00139	CcSEcCtD
Levonorgestrel—Somnolence—Galantamine—Alzheimer's disease	0.000346	0.00138	CcSEcCtD
Levonorgestrel—Arrhythmia—Memantine—Alzheimer's disease	0.000344	0.00137	CcSEcCtD
Levonorgestrel—Dyspepsia—Galantamine—Alzheimer's disease	0.000342	0.00137	CcSEcCtD
Levonorgestrel—Anaemia—Donepezil—Alzheimer's disease	0.000341	0.00136	CcSEcCtD
Levonorgestrel—Alopecia—Memantine—Alzheimer's disease	0.00034	0.00136	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000339	0.00136	CcSEcCtD
Levonorgestrel—Decreased appetite—Galantamine—Alzheimer's disease	0.000338	0.00135	CcSEcCtD
Levonorgestrel—Mental disorder—Memantine—Alzheimer's disease	0.000337	0.00135	CcSEcCtD
Levonorgestrel—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000336	0.00134	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000336	0.00134	CcSEcCtD
Levonorgestrel—Malnutrition—Memantine—Alzheimer's disease	0.000335	0.00134	CcSEcCtD
Levonorgestrel—Fatigue—Galantamine—Alzheimer's disease	0.000335	0.00134	CcSEcCtD
Levonorgestrel—Alopecia—Rivastigmine—Alzheimer's disease	0.000333	0.00133	CcSEcCtD
Levonorgestrel—Constipation—Galantamine—Alzheimer's disease	0.000332	0.00133	CcSEcCtD
Levonorgestrel—Vertigo—Donepezil—Alzheimer's disease	0.000332	0.00132	CcSEcCtD
Levonorgestrel—Syncope—Donepezil—Alzheimer's disease	0.000331	0.00132	CcSEcCtD
Levonorgestrel—Flatulence—Memantine—Alzheimer's disease	0.00033	0.00132	CcSEcCtD
Levonorgestrel—Mental disorder—Rivastigmine—Alzheimer's disease	0.00033	0.00132	CcSEcCtD
Levonorgestrel—Tension—Memantine—Alzheimer's disease	0.000329	0.00131	CcSEcCtD
Levonorgestrel—Erythema—Rivastigmine—Alzheimer's disease	0.000328	0.00131	CcSEcCtD
Levonorgestrel—Malnutrition—Rivastigmine—Alzheimer's disease	0.000328	0.00131	CcSEcCtD
Levonorgestrel—Nervousness—Memantine—Alzheimer's disease	0.000325	0.0013	CcSEcCtD
Levonorgestrel—Loss of consciousness—Donepezil—Alzheimer's disease	0.000324	0.0013	CcSEcCtD
Levonorgestrel—Back pain—Memantine—Alzheimer's disease	0.000324	0.00129	CcSEcCtD
Levonorgestrel—Flatulence—Rivastigmine—Alzheimer's disease	0.000323	0.00129	CcSEcCtD
Levonorgestrel—Cough—Donepezil—Alzheimer's disease	0.000322	0.00129	CcSEcCtD
Levonorgestrel—Tension—Rivastigmine—Alzheimer's disease	0.000322	0.00129	CcSEcCtD
Levonorgestrel—Hypertension—Donepezil—Alzheimer's disease	0.000319	0.00127	CcSEcCtD
Levonorgestrel—Nervousness—Rivastigmine—Alzheimer's disease	0.000318	0.00127	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000318	0.00127	CcSEcCtD
Levonorgestrel—Back pain—Rivastigmine—Alzheimer's disease	0.000317	0.00127	CcSEcCtD
Levonorgestrel—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000315	0.00126	CcSEcCtD
Levonorgestrel—Chest pain—Donepezil—Alzheimer's disease	0.000314	0.00126	CcSEcCtD
Levonorgestrel—Myalgia—Donepezil—Alzheimer's disease	0.000314	0.00126	CcSEcCtD
Levonorgestrel—Anxiety—Donepezil—Alzheimer's disease	0.000313	0.00125	CcSEcCtD
Levonorgestrel—Discomfort—Donepezil—Alzheimer's disease	0.00031	0.00124	CcSEcCtD
Levonorgestrel—Anaemia—Memantine—Alzheimer's disease	0.00031	0.00124	CcSEcCtD
Levonorgestrel—Body temperature increased—Galantamine—Alzheimer's disease	0.000307	0.00123	CcSEcCtD
Levonorgestrel—Abdominal pain—Galantamine—Alzheimer's disease	0.000307	0.00123	CcSEcCtD
Levonorgestrel—Anaemia—Rivastigmine—Alzheimer's disease	0.000303	0.00121	CcSEcCtD
Levonorgestrel—Oedema—Donepezil—Alzheimer's disease	0.000301	0.0012	CcSEcCtD
Levonorgestrel—Vertigo—Memantine—Alzheimer's disease	0.000301	0.0012	CcSEcCtD
Levonorgestrel—Syncope—Memantine—Alzheimer's disease	0.0003	0.0012	CcSEcCtD
Levonorgestrel—Infection—Donepezil—Alzheimer's disease	0.000299	0.0012	CcSEcCtD
Levonorgestrel—Shock—Donepezil—Alzheimer's disease	0.000296	0.00118	CcSEcCtD
Levonorgestrel—Palpitations—Memantine—Alzheimer's disease	0.000296	0.00118	CcSEcCtD
Levonorgestrel—Nervous system disorder—Donepezil—Alzheimer's disease	0.000295	0.00118	CcSEcCtD
Levonorgestrel—Vertigo—Rivastigmine—Alzheimer's disease	0.000295	0.00118	CcSEcCtD
Levonorgestrel—Loss of consciousness—Memantine—Alzheimer's disease	0.000295	0.00118	CcSEcCtD
Levonorgestrel—Syncope—Rivastigmine—Alzheimer's disease	0.000294	0.00117	CcSEcCtD
Levonorgestrel—Cough—Memantine—Alzheimer's disease	0.000292	0.00117	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000291	0.00116	CcSEcCtD
Levonorgestrel—Palpitations—Rivastigmine—Alzheimer's disease	0.00029	0.00116	CcSEcCtD
Levonorgestrel—Hypertension—Memantine—Alzheimer's disease	0.000289	0.00116	CcSEcCtD
Levonorgestrel—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000288	0.00115	CcSEcCtD
Levonorgestrel—Anorexia—Donepezil—Alzheimer's disease	0.000287	0.00115	CcSEcCtD
Levonorgestrel—Hypersensitivity—Galantamine—Alzheimer's disease	0.000286	0.00114	CcSEcCtD
Levonorgestrel—Cough—Rivastigmine—Alzheimer's disease	0.000286	0.00114	CcSEcCtD
Levonorgestrel—Chest pain—Memantine—Alzheimer's disease	0.000285	0.00114	CcSEcCtD
Levonorgestrel—Myalgia—Memantine—Alzheimer's disease	0.000285	0.00114	CcSEcCtD
Levonorgestrel—Anxiety—Memantine—Alzheimer's disease	0.000284	0.00114	CcSEcCtD
Levonorgestrel—Hypertension—Rivastigmine—Alzheimer's disease	0.000283	0.00113	CcSEcCtD
Levonorgestrel—Discomfort—Memantine—Alzheimer's disease	0.000282	0.00113	CcSEcCtD
Levonorgestrel—Chest pain—Rivastigmine—Alzheimer's disease	0.000279	0.00112	CcSEcCtD
Levonorgestrel—Myalgia—Rivastigmine—Alzheimer's disease	0.000279	0.00112	CcSEcCtD
Levonorgestrel—Asthenia—Galantamine—Alzheimer's disease	0.000279	0.00111	CcSEcCtD
Levonorgestrel—Anxiety—Rivastigmine—Alzheimer's disease	0.000278	0.00111	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000277	0.00111	CcSEcCtD
Levonorgestrel—Discomfort—Rivastigmine—Alzheimer's disease	0.000276	0.0011	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000274	0.0011	CcSEcCtD
Levonorgestrel—Oedema—Memantine—Alzheimer's disease	0.000273	0.00109	CcSEcCtD
Levonorgestrel—Insomnia—Donepezil—Alzheimer's disease	0.000272	0.00109	CcSEcCtD
Levonorgestrel—Infection—Memantine—Alzheimer's disease	0.000272	0.00109	CcSEcCtD
Levonorgestrel—Shock—Memantine—Alzheimer's disease	0.000269	0.00107	CcSEcCtD
Levonorgestrel—Dyspnoea—Donepezil—Alzheimer's disease	0.000269	0.00107	CcSEcCtD
Levonorgestrel—Nervous system disorder—Memantine—Alzheimer's disease	0.000268	0.00107	CcSEcCtD
Levonorgestrel—Somnolence—Donepezil—Alzheimer's disease	0.000268	0.00107	CcSEcCtD
Levonorgestrel—Danazol—ESR1—Alzheimer's disease	0.000268	0.0448	CrCbGaD
Levonorgestrel—Oedema—Rivastigmine—Alzheimer's disease	0.000268	0.00107	CcSEcCtD
Levonorgestrel—Diarrhoea—Galantamine—Alzheimer's disease	0.000266	0.00106	CcSEcCtD
Levonorgestrel—Infection—Rivastigmine—Alzheimer's disease	0.000266	0.00106	CcSEcCtD
Levonorgestrel—Skin disorder—Memantine—Alzheimer's disease	0.000266	0.00106	CcSEcCtD
Levonorgestrel—Dyspepsia—Donepezil—Alzheimer's disease	0.000265	0.00106	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Memantine—Alzheimer's disease	0.000264	0.00106	CcSEcCtD
Levonorgestrel—Shock—Rivastigmine—Alzheimer's disease	0.000263	0.00105	CcSEcCtD
Levonorgestrel—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000262	0.00105	CcSEcCtD
Levonorgestrel—Decreased appetite—Donepezil—Alzheimer's disease	0.000262	0.00105	CcSEcCtD
Levonorgestrel—Anorexia—Memantine—Alzheimer's disease	0.000261	0.00104	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00026	0.00104	CcSEcCtD
Levonorgestrel—Skin disorder—Rivastigmine—Alzheimer's disease	0.00026	0.00104	CcSEcCtD
Levonorgestrel—Fatigue—Donepezil—Alzheimer's disease	0.00026	0.00104	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000259	0.00103	CcSEcCtD
Levonorgestrel—Pain—Donepezil—Alzheimer's disease	0.000258	0.00103	CcSEcCtD
Levonorgestrel—Constipation—Donepezil—Alzheimer's disease	0.000258	0.00103	CcSEcCtD
Levonorgestrel—Dizziness—Galantamine—Alzheimer's disease	0.000257	0.00103	CcSEcCtD
Levonorgestrel—Anorexia—Rivastigmine—Alzheimer's disease	0.000255	0.00102	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000249	0.000995	CcSEcCtD
Levonorgestrel—Ethinyl Estradiol—ESR1—Alzheimer's disease	0.000248	0.0415	CrCbGaD
Levonorgestrel—Insomnia—Memantine—Alzheimer's disease	0.000247	0.000988	CcSEcCtD
Levonorgestrel—Vomiting—Galantamine—Alzheimer's disease	0.000247	0.000987	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000246	0.000984	CcSEcCtD
Levonorgestrel—Rash—Galantamine—Alzheimer's disease	0.000245	0.000979	CcSEcCtD
Levonorgestrel—Dermatitis—Galantamine—Alzheimer's disease	0.000245	0.000978	CcSEcCtD
Levonorgestrel—Dyspnoea—Memantine—Alzheimer's disease	0.000244	0.000974	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000244	0.000974	CcSEcCtD
Levonorgestrel—Headache—Galantamine—Alzheimer's disease	0.000243	0.000973	CcSEcCtD
Levonorgestrel—Somnolence—Memantine—Alzheimer's disease	0.000243	0.000971	CcSEcCtD
Levonorgestrel—Insomnia—Rivastigmine—Alzheimer's disease	0.000242	0.000967	CcSEcCtD
Levonorgestrel—Dyspepsia—Memantine—Alzheimer's disease	0.000241	0.000962	CcSEcCtD
Levonorgestrel—Urticaria—Donepezil—Alzheimer's disease	0.000239	0.000956	CcSEcCtD
Levonorgestrel—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000239	0.000953	CcSEcCtD
Levonorgestrel—Abdominal pain—Donepezil—Alzheimer's disease	0.000238	0.000951	CcSEcCtD
Levonorgestrel—Body temperature increased—Donepezil—Alzheimer's disease	0.000238	0.000951	CcSEcCtD
Levonorgestrel—Somnolence—Rivastigmine—Alzheimer's disease	0.000238	0.00095	CcSEcCtD
Levonorgestrel—Decreased appetite—Memantine—Alzheimer's disease	0.000238	0.00095	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000236	0.000943	CcSEcCtD
Levonorgestrel—Fatigue—Memantine—Alzheimer's disease	0.000236	0.000942	CcSEcCtD
Levonorgestrel—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000236	0.000941	CcSEcCtD
Levonorgestrel—Constipation—Memantine—Alzheimer's disease	0.000234	0.000934	CcSEcCtD
Levonorgestrel—Pain—Memantine—Alzheimer's disease	0.000234	0.000934	CcSEcCtD
Levonorgestrel—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000233	0.000929	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000231	0.000923	CcSEcCtD
Levonorgestrel—Nausea—Galantamine—Alzheimer's disease	0.000231	0.000922	CcSEcCtD
Levonorgestrel—Fatigue—Rivastigmine—Alzheimer's disease	0.000231	0.000922	CcSEcCtD
Levonorgestrel—Pain—Rivastigmine—Alzheimer's disease	0.000229	0.000914	CcSEcCtD
Levonorgestrel—Constipation—Rivastigmine—Alzheimer's disease	0.000229	0.000914	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000224	0.000893	CcSEcCtD
Levonorgestrel—Hypersensitivity—Donepezil—Alzheimer's disease	0.000222	0.000887	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000219	0.000874	CcSEcCtD
Levonorgestrel—Urticaria—Memantine—Alzheimer's disease	0.000217	0.000868	CcSEcCtD
Levonorgestrel—Abdominal pain—Memantine—Alzheimer's disease	0.000216	0.000864	CcSEcCtD
Levonorgestrel—Body temperature increased—Memantine—Alzheimer's disease	0.000216	0.000864	CcSEcCtD
Levonorgestrel—Asthenia—Donepezil—Alzheimer's disease	0.000216	0.000863	CcSEcCtD
Levonorgestrel—Pruritus—Donepezil—Alzheimer's disease	0.000213	0.000851	CcSEcCtD
Levonorgestrel—Urticaria—Rivastigmine—Alzheimer's disease	0.000213	0.000849	CcSEcCtD
Levonorgestrel—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000211	0.000845	CcSEcCtD
Levonorgestrel—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000211	0.000845	CcSEcCtD
Levonorgestrel—Diarrhoea—Donepezil—Alzheimer's disease	0.000206	0.000823	CcSEcCtD
Levonorgestrel—Hypersensitivity—Memantine—Alzheimer's disease	0.000201	0.000805	CcSEcCtD
Levonorgestrel—Dizziness—Donepezil—Alzheimer's disease	0.000199	0.000796	CcSEcCtD
Levonorgestrel—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000197	0.000788	CcSEcCtD
Levonorgestrel—Asthenia—Memantine—Alzheimer's disease	0.000196	0.000784	CcSEcCtD
Levonorgestrel—Pruritus—Memantine—Alzheimer's disease	0.000193	0.000773	CcSEcCtD
Levonorgestrel—Asthenia—Rivastigmine—Alzheimer's disease	0.000192	0.000767	CcSEcCtD
Levonorgestrel—Vomiting—Donepezil—Alzheimer's disease	0.000192	0.000765	CcSEcCtD
Levonorgestrel—Rash—Donepezil—Alzheimer's disease	0.00019	0.000759	CcSEcCtD
Levonorgestrel—Dermatitis—Donepezil—Alzheimer's disease	0.00019	0.000758	CcSEcCtD
Levonorgestrel—Pruritus—Rivastigmine—Alzheimer's disease	0.000189	0.000756	CcSEcCtD
Levonorgestrel—Headache—Donepezil—Alzheimer's disease	0.000189	0.000754	CcSEcCtD
Levonorgestrel—Diarrhoea—Memantine—Alzheimer's disease	0.000187	0.000748	CcSEcCtD
Levonorgestrel—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000183	0.000731	CcSEcCtD
Levonorgestrel—Dizziness—Memantine—Alzheimer's disease	0.000181	0.000723	CcSEcCtD
Levonorgestrel—Nausea—Donepezil—Alzheimer's disease	0.000179	0.000715	CcSEcCtD
Levonorgestrel—Dizziness—Rivastigmine—Alzheimer's disease	0.000177	0.000707	CcSEcCtD
Levonorgestrel—Vomiting—Memantine—Alzheimer's disease	0.000174	0.000695	CcSEcCtD
Levonorgestrel—Rash—Memantine—Alzheimer's disease	0.000172	0.000689	CcSEcCtD
Levonorgestrel—Dermatitis—Memantine—Alzheimer's disease	0.000172	0.000688	CcSEcCtD
Levonorgestrel—Headache—Memantine—Alzheimer's disease	0.000171	0.000684	CcSEcCtD
Levonorgestrel—Vomiting—Rivastigmine—Alzheimer's disease	0.00017	0.00068	CcSEcCtD
Levonorgestrel—Rash—Rivastigmine—Alzheimer's disease	0.000169	0.000674	CcSEcCtD
Levonorgestrel—Dermatitis—Rivastigmine—Alzheimer's disease	0.000169	0.000673	CcSEcCtD
Levonorgestrel—Headache—Rivastigmine—Alzheimer's disease	0.000168	0.00067	CcSEcCtD
Levonorgestrel—Nausea—Memantine—Alzheimer's disease	0.000162	0.000649	CcSEcCtD
Levonorgestrel—Nausea—Rivastigmine—Alzheimer's disease	0.000159	0.000635	CcSEcCtD
Levonorgestrel—Progesterone—ESR1—Alzheimer's disease	0.000139	0.0232	CrCbGaD
Levonorgestrel—Progesterone—CYP2D6—Alzheimer's disease	8.25e-05	0.0138	CrCbGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	5.8e-05	0.000672	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	5.79e-05	0.00067	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HSD17B10—Alzheimer's disease	5.76e-05	0.000667	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	5.71e-05	0.000661	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	5.65e-05	0.000654	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	5.63e-05	0.000652	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL6—Alzheimer's disease	5.63e-05	0.000651	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PPARG—Alzheimer's disease	5.63e-05	0.000651	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	5.58e-05	0.000646	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	5.58e-05	0.000645	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDK5—Alzheimer's disease	5.57e-05	0.000645	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	5.56e-05	0.000644	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—AKT1—Alzheimer's disease	5.56e-05	0.000644	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP46A1—Alzheimer's disease	5.55e-05	0.000642	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—INS—Alzheimer's disease	5.52e-05	0.000639	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—ESR1—Alzheimer's disease	5.46e-05	0.000632	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—EIF2S1—Alzheimer's disease	5.38e-05	0.000623	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HTR6—Alzheimer's disease	5.36e-05	0.000621	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ND1—Alzheimer's disease	5.36e-05	0.00062	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—AKT1—Alzheimer's disease	5.31e-05	0.000615	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	5.28e-05	0.000611	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—TFAM—Alzheimer's disease	5.25e-05	0.000607	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.24e-05	0.000606	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	5.18e-05	0.0006	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—IL6—Alzheimer's disease	5.16e-05	0.000597	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	5.13e-05	0.000593	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—PPARG—Alzheimer's disease	4.98e-05	0.000576	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	4.91e-05	0.000569	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—AKT1—Alzheimer's disease	4.91e-05	0.000569	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	4.87e-05	0.000564	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PSENEN—Alzheimer's disease	4.87e-05	0.000564	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—NOS3—Alzheimer's disease	4.84e-05	0.00056	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APH1A—Alzheimer's disease	4.8e-05	0.000556	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.79e-05	0.000554	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	4.77e-05	0.000552	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—AKT1—Alzheimer's disease	4.76e-05	0.000551	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	4.73e-05	0.000548	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NCSTN—Alzheimer's disease	4.68e-05	0.000541	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	4.63e-05	0.000536	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	4.62e-05	0.000535	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LRP1—Alzheimer's disease	4.56e-05	0.000528	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GFAP—Alzheimer's disease	4.45e-05	0.000515	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GAL—Alzheimer's disease	4.45e-05	0.000515	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PTGS2—Alzheimer's disease	4.43e-05	0.000512	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	4.4e-05	0.000509	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	4.34e-05	0.000503	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	4.32e-05	0.000499	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TTR—Alzheimer's disease	4.31e-05	0.000499	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	4.3e-05	0.000497	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	4.28e-05	0.000495	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	4.2e-05	0.000486	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—ESR1—Alzheimer's disease	4.16e-05	0.000481	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.14e-05	0.000479	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.13e-05	0.000478	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—EIF2S1—Alzheimer's disease	4.1e-05	0.000474	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	4.06e-05	0.000469	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	4.02e-05	0.000465	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	3.95e-05	0.000457	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—A2M—Alzheimer's disease	3.93e-05	0.000454	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	3.85e-05	0.000445	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PSEN2—Alzheimer's disease	3.8e-05	0.00044	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—PPARG—Alzheimer's disease	3.79e-05	0.000439	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PYY—Alzheimer's disease	3.77e-05	0.000436	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.76e-05	0.000435	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	3.71e-05	0.00043	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	3.65e-05	0.000422	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	3.64e-05	0.000422	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	3.58e-05	0.000414	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NPY—Alzheimer's disease	3.5e-05	0.000405	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IAPP—Alzheimer's disease	3.48e-05	0.000402	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CHAT—Alzheimer's disease	3.45e-05	0.0004	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—TPI1—Alzheimer's disease	3.45e-05	0.0004	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CRH—Alzheimer's disease	3.38e-05	0.000391	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	3.35e-05	0.000387	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	3.32e-05	0.000385	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—MAOB—Alzheimer's disease	3.31e-05	0.000383	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDK5—Alzheimer's disease	3.27e-05	0.000378	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NPS—Alzheimer's disease	3.2e-05	0.00037	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GAPDH—Alzheimer's disease	3.19e-05	0.000369	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PPP3CA—Alzheimer's disease	3.18e-05	0.000368	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—EIF2S1—Alzheimer's disease	3.16e-05	0.000365	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.15e-05	0.000365	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HTR6—Alzheimer's disease	3.15e-05	0.000364	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PTK2B—Alzheimer's disease	3.14e-05	0.000363	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	3.14e-05	0.000363	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	3.12e-05	0.000362	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.12e-05	0.000361	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	3.1e-05	0.000358	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—A2M—Alzheimer's disease	3.08e-05	0.000356	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SST—Alzheimer's disease	3.05e-05	0.000353	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NTRK2—Alzheimer's disease	3.05e-05	0.000353	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GAB2—Alzheimer's disease	3.05e-05	0.000353	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—IL6—Alzheimer's disease	3.03e-05	0.00035	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GSK3A—Alzheimer's disease	3.03e-05	0.00035	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	3.02e-05	0.000349	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APP—Alzheimer's disease	2.97e-05	0.000344	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—PPARG—Alzheimer's disease	2.92e-05	0.000338	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PSENEN—Alzheimer's disease	2.86e-05	0.000331	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APH1A—Alzheimer's disease	2.82e-05	0.000326	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	2.81e-05	0.000325	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PLCB1—Alzheimer's disease	2.81e-05	0.000325	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—AKT1—Alzheimer's disease	2.79e-05	0.000323	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.75e-05	0.000319	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.74e-05	0.000318	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NCSTN—Alzheimer's disease	2.74e-05	0.000318	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ACHE—Alzheimer's disease	2.68e-05	0.00031	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LRP1—Alzheimer's disease	2.68e-05	0.00031	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—INPP5D—Alzheimer's disease	2.65e-05	0.000306	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—ESR1—Alzheimer's disease	2.63e-05	0.000304	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NGFR—Alzheimer's disease	2.62e-05	0.000303	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GFAP—Alzheimer's disease	2.61e-05	0.000303	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GAL—Alzheimer's disease	2.61e-05	0.000303	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADAM10—Alzheimer's disease	2.56e-05	0.000296	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NOTCH1—Alzheimer's disease	2.54e-05	0.000294	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS1—Alzheimer's disease	2.51e-05	0.00029	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ENO1—Alzheimer's disease	2.51e-05	0.00029	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP2D6—Alzheimer's disease	2.46e-05	0.000285	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.43e-05	0.000281	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—S100B—Alzheimer's disease	2.42e-05	0.00028	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PPARG—Alzheimer's disease	2.4e-05	0.000277	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—BCHE—Alzheimer's disease	2.33e-05	0.00027	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.33e-05	0.000269	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—A2M—Alzheimer's disease	2.3e-05	0.000267	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IGF2—Alzheimer's disease	2.3e-05	0.000267	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PSEN2—Alzheimer's disease	2.23e-05	0.000258	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IGF1R—Alzheimer's disease	2.23e-05	0.000258	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—AKT1—Alzheimer's disease	2.23e-05	0.000258	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PLCB1—Alzheimer's disease	2.2e-05	0.000255	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.16e-05	0.00025	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LPL—Alzheimer's disease	2.14e-05	0.000247	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ABCA1—Alzheimer's disease	2.13e-05	0.000247	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MEF2C—Alzheimer's disease	2.12e-05	0.000245	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PRKCG—Alzheimer's disease	2.08e-05	0.00024	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.06e-05	0.000239	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NPY—Alzheimer's disease	2.05e-05	0.000238	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IAPP—Alzheimer's disease	2.04e-05	0.000236	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NGF—Alzheimer's disease	2.02e-05	0.000234	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—ESR1—Alzheimer's disease	2e-05	0.000232	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CRH—Alzheimer's disease	1.98e-05	0.000229	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCR5—Alzheimer's disease	1.97e-05	0.000228	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.94e-05	0.000225	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NOTCH1—Alzheimer's disease	1.94e-05	0.000224	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HTR2A—Alzheimer's disease	1.93e-05	0.000223	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NPS—Alzheimer's disease	1.88e-05	0.000217	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.87e-05	0.000216	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTK2B—Alzheimer's disease	1.84e-05	0.000213	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.84e-05	0.000213	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARGC1A—Alzheimer's disease	1.84e-05	0.000213	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HMOX1—Alzheimer's disease	1.83e-05	0.000212	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARG—Alzheimer's disease	1.83e-05	0.000211	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CALM1—Alzheimer's disease	1.8e-05	0.000208	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SST—Alzheimer's disease	1.79e-05	0.000207	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GAB2—Alzheimer's disease	1.79e-05	0.000207	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NTRK2—Alzheimer's disease	1.79e-05	0.000207	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LEP—Alzheimer's disease	1.79e-05	0.000207	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOE—Alzheimer's disease	1.79e-05	0.000207	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GSK3A—Alzheimer's disease	1.78e-05	0.000206	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CAV1—Alzheimer's disease	1.77e-05	0.000205	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.75e-05	0.000203	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APP—Alzheimer's disease	1.75e-05	0.000202	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ESR1—Alzheimer's disease	1.71e-05	0.000198	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—F2—Alzheimer's disease	1.69e-05	0.000195	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.68e-05	0.000195	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—LPL—Alzheimer's disease	1.67e-05	0.000194	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOTCH1—Alzheimer's disease	1.65e-05	0.000191	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PLCB1—Alzheimer's disease	1.65e-05	0.000191	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.62e-05	0.000187	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.56e-05	0.000181	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GSK3B—Alzheimer's disease	1.55e-05	0.000179	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CREB1—Alzheimer's disease	1.54e-05	0.000178	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NGFR—Alzheimer's disease	1.54e-05	0.000178	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—INS—Alzheimer's disease	1.53e-05	0.000177	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—MTHFR—Alzheimer's disease	1.51e-05	0.000174	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCL2—Alzheimer's disease	1.5e-05	0.000174	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADAM10—Alzheimer's disease	1.5e-05	0.000174	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NOTCH1—Alzheimer's disease	1.49e-05	0.000173	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IGF1—Alzheimer's disease	1.48e-05	0.000171	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—S100B—Alzheimer's disease	1.42e-05	0.000164	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CALM1—Alzheimer's disease	1.41e-05	0.000163	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARG—Alzheimer's disease	1.41e-05	0.000163	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOE—Alzheimer's disease	1.4e-05	0.000162	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CAV1—Alzheimer's disease	1.39e-05	0.000161	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF2—Alzheimer's disease	1.35e-05	0.000156	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOS3—Alzheimer's disease	1.34e-05	0.000155	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF1R—Alzheimer's disease	1.31e-05	0.000151	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LPL—Alzheimer's disease	1.25e-05	0.000145	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MEF2C—Alzheimer's disease	1.24e-05	0.000144	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARG—Alzheimer's disease	1.22e-05	0.000141	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRKCG—Alzheimer's disease	1.22e-05	0.000141	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—INS—Alzheimer's disease	1.2e-05	0.000139	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NGF—Alzheimer's disease	1.19e-05	0.000137	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCR5—Alzheimer's disease	1.15e-05	0.000134	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CASP3—Alzheimer's disease	1.14e-05	0.000132	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HTR2A—Alzheimer's disease	1.13e-05	0.000131	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CALM1—Alzheimer's disease	1.05e-05	0.000122	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NOS3—Alzheimer's disease	1.05e-05	0.000122	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOE—Alzheimer's disease	1.05e-05	0.000122	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LEP—Alzheimer's disease	1.05e-05	0.000122	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAPK8—Alzheimer's disease	1.05e-05	0.000121	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CAV1—Alzheimer's disease	1.04e-05	0.00012	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.01e-05	0.000117	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.01e-05	0.000117	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—F2—Alzheimer's disease	9.91e-06	0.000115	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOTCH1—Alzheimer's disease	9.69e-06	0.000112	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MAOB—Alzheimer's disease	9.66e-06	0.000112	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—Alzheimer's disease	9.66e-06	0.000112	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—Alzheimer's disease	9.61e-06	0.000111	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—AKT1—Alzheimer's disease	9.48e-06	0.00011	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	9.3e-06	0.000108	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GSK3B—Alzheimer's disease	9.1e-06	0.000105	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CREB1—Alzheimer's disease	9.02e-06	0.000104	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—A2M—Alzheimer's disease	8.98e-06	0.000104	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—INS—Alzheimer's disease	8.97e-06	0.000104	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TGFB1—Alzheimer's disease	8.87e-06	0.000103	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL2—Alzheimer's disease	8.83e-06	0.000102	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF1—Alzheimer's disease	8.68e-06	0.0001	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOS3—Alzheimer's disease	7.87e-06	9.11e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ACHE—Alzheimer's disease	7.81e-06	9.04e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	7.72e-06	8.94e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	7.32e-06	8.47e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ENO1—Alzheimer's disease	7.32e-06	8.47e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TP53—Alzheimer's disease	7.3e-06	8.45e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—AKT1—Alzheimer's disease	7.22e-06	8.36e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	7.18e-06	8.31e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—BCHE—Alzheimer's disease	6.81e-06	7.88e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CASP3—Alzheimer's disease	6.68e-06	7.73e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6—Alzheimer's disease	6.68e-06	7.73e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	6.42e-06	7.43e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	6.23e-06	7.2e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT1—Alzheimer's disease	6.16e-06	7.13e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAPK8—Alzheimer's disease	6.14e-06	7.11e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—Alzheimer's disease	5.67e-06	6.56e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—AKT1—Alzheimer's disease	5.56e-06	6.44e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	5.37e-06	6.21e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	5.34e-06	6.18e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TGFB1—Alzheimer's disease	5.2e-06	6.02e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LPL—Alzheimer's disease	4.88e-06	5.65e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKT1—Alzheimer's disease	4.83e-06	5.59e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	4.4e-06	5.09e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TP53—Alzheimer's disease	4.28e-06	4.96e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CALM1—Alzheimer's disease	4.11e-06	4.76e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOE—Alzheimer's disease	4.09e-06	4.74e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CAV1—Alzheimer's disease	4.06e-06	4.7e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6—Alzheimer's disease	3.92e-06	4.54e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT1—Alzheimer's disease	3.62e-06	4.19e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.57e-06	4.13e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—INS—Alzheimer's disease	3.5e-06	4.05e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.07e-06	3.55e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.81e-06	3.25e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.41e-06	1.63e-05	CbGpPWpGaD
